ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Nexxen International Ltd

Nexxen International Ltd (NEXN)

405.00
7.00
(1.76%)
Cerrado 04 Enero 10:30AM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
405.00
Postura de Compra
404.50
Postura de Venta
405.00
Volume Operado de la Acción
688,229
394.50 Rango del Día 406.00
185.00 Rango de 52 semanas 410.00
Capitalización de Mercado [m]
Precio Anterior
398.00
Precio de Apertura
396.50
Última hora de negociación
Volumen financiero
2,773,060p
Precio Promedio Ponderado
402.927
Volumen promedio (3 m)
480,977
Acciones en circulación
135,241,344
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-25.49
Beneficio por acción (BPA)
-0.16
turnover
331.99M
Beneficio neto
-21.49M

Acerca de Nexxen International Ltd

Sector
Advertising Agencies
Industria
Advertising Agencies
Sede
Tel Aviv, Center, Isr
Fundado
-
Nexxen International Ltd is listed in the Advertising Agencies sector of the London Stock Exchange with ticker NEXN. The last closing price for Nexxen was 398p. Over the last year, Nexxen shares have traded in a share price range of 185.00p to 410.00p.

Nexxen currently has 135,241,344 shares in issue. The market capitalisation of Nexxen is £538.26 million. Nexxen has a price to earnings ratio (PE ratio) of -25.49.

NEXN Últimas noticias

Nexxen International Ltd Share buyback-transaction in own shares

Nexxen International Ltd 03 January 2025   3 January 2025 Nexxen International Ltd   ("Nexxen" or the "Company")   Share buyback-transaction in own shares   Nexxen International Ltd...

Nexxen International Ltd Total Voting Rights

Nexxen International Ltd 02 January 2025   2 January 2025   Nexxen International Ltd   ("Nexxen" or the "Company")    Total Voting Rights   For the purposes of the Financial Conduct...

Nexxen International Ltd Share buyback-transaction in own shares

Nexxen International Ltd 02 January 2025   2 January 2025 Nexxen International Ltd   ("Nexxen" or the "Company")   Share buyback-transaction in own shares   Nexxen International Ltd...

Nexxen International Ltd Share buyback-transaction in own shares

Nexxen International Ltd 31 December 2024   31 December 2024 Nexxen International Ltd   ("Nexxen" or the "Company")   Share buyback-transaction in own shares   Nexxen International Ltd...

Nexxen International Ltd Share buyback-transaction in own shares

Nexxen International Ltd 30 December 2024   30 December 2024 Nexxen International Ltd   ("Nexxen" or the "Company")   Share buyback-transaction in own shares   Nexxen International Ltd...

Nexxen International Ltd Share buyback-transaction in own shares

Nexxen International Ltd 27 December 2024   27 December 2024 Nexxen International Ltd   ("Nexxen" or the "Company")   Share buyback-transaction in own shares   Nexxen International Ltd...

Nexxen International Ltd Share buyback-transaction in own shares

Nexxen International Ltd 24 December 2024   24 December 2024 Nexxen International Ltd   ("Nexxen" or the "Company")   Share buyback-transaction in own shares   Nexxen International Ltd...

Nexxen International Ltd Share buyback-transaction in own shares

Nexxen International Ltd 23 December 2024   23 December 2024 Nexxen International Ltd   ("Nexxen" or the "Company")   Share buyback-transaction in own shares   Nexxen International Ltd...

Nexxen International Ltd Results of Annual General Meeting

Nexxen International Ltd 20 December 2024   20 December 2024 Nexxen International Ltd ("Nexxen" or the "Company") Results of Annual General Meeting   Nexxen International Ltd. (AIM/NASDAQ:...

Nexxen International Ltd Share buyback-transaction in own shares

Nexxen International Ltd 20 December 2024   20 December 2024 Nexxen International Ltd   ("Nexxen" or the "Company")   Share buyback-transaction in own shares   Nexxen International Ltd...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
120.496277915633403407391.5265635398.23035252DE
4153.84615384615390410378.5548564393.15122471DE
12119.541.8563922942285.5410284480977361.04834354DE
2615964.6341463415246410230367294327.50526921DE
52200.497.9472140762204.6410185379171268.9280401DE
156-153-27.4193548387558642132.1450039326.82796989DE
260236139.64497041416986482.5441913385.82302853DE

NEXN - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Nexxen?
El precio actual de las acciones de Nexxen es 405.00p
¿Cuántas acciones de Nexxen están en circulación?
Nexxen tiene 135,241,344 acciones en circulación
¿Cuál es la capitalización de mercado de Nexxen?
La capitalización de mercado de Nexxen es GBP 538.26M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Nexxen?
Nexxen ha negociado en un rango de 185.00p a 410.00p durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Nexxen?
El ratio precio/beneficio de Nexxen es -25.49
¿Cuál es el ratio de efectivo a ventas de Nexxen?
El ratio de efectivo a ventas de Nexxen es 1.65
¿Cuál es la moneda de reporte de Nexxen?
Nexxen presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Nexxen?
El último ingresos anual de Nexxen es USD 331.99M
¿Cuál es el último beneficio anual de Nexxen?
El último beneficio anual de Nexxen es USD -21.49M
¿Cuál es la dirección registrada de Nexxen?
La dirección registrada de Nexxen es 82 YIGAL ALON ST, 13TH FLOOR, TEL AVIV, CENTER, 6789124
¿Cuál es la dirección del sitio web de Nexxen?
La dirección del sitio web de Nexxen es www.tremorinternational.com
¿En qué sector industrial opera Nexxen?
Nexxen opera en el sector ADVERTISING AGENCIES

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M
crescentmotor crescentmotor 2 minutos hace
Seems like a lot of silly effort for no impact on share price come Monday-Friday.

With AVXL's MAA being accepted and under review, a favorable/supportive peer review article about to be officially released in mass distribution, and presentations of OLE trial data at the prestigious JP
AVXL JPM
mauismart mauismart 4 minutos hace
I just bought a. 2000 Toyota echo with over 100k miles for only $1200 and she gets over 30 miles to the gallon. I saved my avxl share
AVXL
carvajal carvajal 4 minutos hace

Brian's ties to Brazil date back to 2021.

" style="font-size: 1em"#HUMBL continues to advance. Please do not mistake silence for weakness."

 
HMBL
shortridge3w shortridge3w 5 minutos hace
Regarding the 1.8 point difference of ADAS-cog13 between dosed and placebo, the worst estimate could be done by extending the dosed curve 4 months, which would result in 1 point increase. This can be verified with the open label extension data.
AVXL
Risk Risk 5 minutos hace
Yes Golf. I Agree, Just want to get out man break even if it's a possiblility???
Happy to hear you made it back on Quantum stocks.
AFFU
TURCH TURCH 5 minutos hace
Yup have Rr and krknf if u find any others let me know!


Regards
doccjc doccjc 5 minutos hace
Wonder if we'll get an update on Monday ?
First full week of trading since the India  human trials announcement 
Positive human trial results may cause the stock to run imo .
RDGL
theorysuit theorysuit 7 minutos hace
Immunomedics was $10B before Gilead bought them for Trodelvy. They paid $21B before it had FDA approval.

Wrong, IMMU already had accelerated approval in mTNBC by FDA, and had confirmatory data that was stopped early for hitting their pfs and OS endpoints to support full approval. A
NWBO
doccjc doccjc 8 minutos hace
Sure as hell feels different. Obgoing human trials , IDE about to be submitted .  We're about to find out if this works in humans as well as it does in animals. No reason it shouldn't .  Share price is about to take off imo . 
RDGL
StockItOut StockItOut 10 minutos hace
Bitcoin, for example, is not lawful money.

The Note is: money or shares or both. Standard.

You really are a nutjob.
XERI
againstallodds againstallodds 11 minutos hace
A/S tells you where JarHead is headed….
NBRI
blackhawks blackhawks 12 minutos hace
Curtain is still with us.

https://en.wikipedia.org/wiki/Jane_Curtin
getmoreshares getmoreshares 12 minutos hace
.0005 next!
KATX
StockItOut StockItOut 12 minutos hace
The Note is either/or you moron.
XERI
SSKILLZ1 SSKILLZ1 13 minutos hace
Mr. Sheep Picks

There will two Mr. Sheep this contest one with cash and one without. Hope this helps.
[pre]
38 Alias: MR. SHEEP

Symbol
1 $$
2 CCEL 4-3/4 Positions
3 ETCC
4 OPXS
5
ETCC VNDA
georgejjl georgejjl 13 minutos hace
Don't forger Ern Heaven from the Phase 2a trial.

https://www.youtube.com/watch?v=8orzf4UXNLA

Good luck and GOD bless,
AVXL
quester614 quester614 13 minutos hace
There is a reason the clause lawful money is in the Auctus loan. They were never going to sell 1 shares or OPTION. ANY DECENT LAWYER should know that a specific language is used for reasons in contracts.

LOLOLOLhttps://investorshub.advfn.com/uimage/uploads/2025/1/4/qwgpiScreenshot_20
XERI
Manspider Manspider 14 minutos hace
Foolish rabbit … tricks are for kids! :-D
ASII
jay_tee jay_tee 15 minutos hace
It's obvious you still believe in Santa if you really believe I'm a paid basher. I've never once bashed RNVA
RNVA
solong solong 15 minutos hace
Read all of the tweets from the company, they aren't going for Pink Current. Do you have any idea as to who is in charge? Read the company tweets.

They've laid out where this is heading and Pink Current is not the destination.
SYIN
imho imho 16 minutos hace
I have noticed that posts by Doc and Investor critiquing Blarcamisine, avoid comparisons to the MABs. They would be correct in stating that the MABs have nothing to do in assessing if Blarcamisine works (vs a placebo). That is the premise and the basis for their conclusions.

However,
AVXL

Su Consulta Reciente

Delayed Upgrade Clock